Benefiting from 'evil': an incipient moral problem in human stem cell research

Area of Science:

• Bioethics
• Moral Philosophy
• Stem Cell Research

Background:

• The ethical debate surrounding stem cell research often involves the source of the cells, particularly human embryonic stem cells.
• Past ethical discussions have addressed benefiting from research derived from morally questionable sources, such as fetal tissue or Nazi data.
• The therapeutic promise of stem cell research intensifies the need to clarify the moral implications of benefiting from embryo destruction.

Purpose of the Study:

• To analyze the conditions under which benefiting from others' wrongdoing constitutes moral complicity.
• To apply this ethical framework to the use of human embryonic stem cells.
• To determine if individuals who oppose embryo destruction can ethically use stem cells derived from embryos.

Main Methods:

• Philosophical argumentation and ethical analysis.
• Examination of the concept of moral complicity.
• Application of ethical principles to specific scenarios in stem cell research.

Main Results:

• Benefiting from wrongdoing is considered morally wrong under three conditions: agency, encouragement of repetition, or legitimization of the practice.
• The derivation of most human embryonic stem cell lines involves actions that may be considered wrongful by opponents of embryo destruction.
• Using these stem cells may not incur moral blame if it does not meet the established conditions for complicity.

Conclusions:

• Individuals opposing embryo destruction can ethically utilize human embryonic stem cells.
• The ethical permissibility hinges on whether the use of these cells encourages or legitimizes embryo destruction.
• This ethical analysis provides a framework for navigating the moral complexities of stem cell research and its applications.